Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Examination of Trends in Multiple Myeloma Trial Patient Experiences
ClinicalTrials.gov study NCT05860179. IPD Sharing: UNDECIDED. Countries: 0. Publications: 3.
Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma
ClinicalTrials.gov study NCT04270409. IPD Sharing: YES. Countries: 24. Publications: 0.
Efficacy of Response-adapted Treatment in Patients With Multiple Myeloma Candidates for Bone Marrow Transplantation
ClinicalTrials.gov study NCT05697913. IPD Sharing: NO. Countries: 0. Publications: 5.
A Study of Carfilzomib Plus Dexamethasone in Adults With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
ClinicalTrials.gov study NCT03512353. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01063907. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Phase II Study of Dasatinib in the Treatment of Relapsed or Plateau Phase Multiple Myeloma
ClinicalTrials.gov study NCT00429949. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04879043. IPD Sharing: NO. Countries: 4. Publications: 0.
Study of High Dose Carfilzomib in Multiple Myeloma Patients Who Have Progressed On Standard Dose Carfilzomib
ClinicalTrials.gov study NCT01775553. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Avelumab in Combination With Hypofractionated Radiotherapy in Patients With Relapsed Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03910439. IPD Sharing: NO. Countries: 1. Publications: 0.
Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT00635024. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00567229. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Multiple Myeloma Patients Double Refractory to Bortezomib and Lenalidomide
ClinicalTrials.gov study NCT03117361. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Multiple Myeloma Trial in Patients With Bone Metastases
ClinicalTrials.gov study NCT00104104. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SMAC Mimetic LCL161 Alone or With Cyclophosphamide in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01955434. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Velcade® and Bone Formation in Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00128921. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide and Dexamethasone With or Without Anakinra in Treating Patients With Early Stage Multiple Myeloma
ClinicalTrials.gov study NCT02492750. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Desipramine Hydrochloride and Filgrastim For Stem Cell Mobilization in Patients With Multiple Myeloma Undergoing Stem Cell Transplant
ClinicalTrials.gov study NCT01899326. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Daratumumab, Azacitidine, and Dexamethasone for Treatment of Patients With Recurrent or Refractory Multiple Myeloma Previously Treated With Daratumumab
ClinicalTrials.gov study NCT04407442. IPD Sharing: NO. Countries: 1. Publications: 0.
Mobilization of Stem Cells With AMD3100 (Plerixafor) in Combination With G-CSF in Multiple Myeloma Patients
ClinicalTrials.gov study NCT05087212. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Bendamustine and IXAZOMIB (MLN9708) Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02477215. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.